Baseline characteristics of study subjects with and without sickle cell trait
Variable . | Control subjects . | SCT subjects . | P . |
---|---|---|---|
Age, y | 32 (32.2 ± 9.5) | 33.5 (35.2 ± 8.6) | .25 |
Gender, F/M | 4/4 | 6/3 | .84 |
CD34+, 106/L | 1.0 (1.8 ± 1.2) | 2.0 (1.7 ± 0.9) | .90 |
WBC, 109/L | 6.61 (6.55 ± 1.72) | 4.47 (4.90 ± 2.07) | .05 |
Hemoglobin, g/L | 1.24 (1.32 ± 0.14) | 1.25 (1.32 ± 0.14) | .46 |
Platelet, 109/L | 256 (244 ± 32) | 265 (265 ± 96) | .28 |
ANC, 109/L | 4.20 (4.02 ± 1.65) | 1.93 (2.53 ± 1.49) | .04 |
Hematocrit, % | 38.2 (39.8 ± 4.5) | 37.7 (39.4 ± 4.1) | .42 |
Variable . | Control subjects . | SCT subjects . | P . |
---|---|---|---|
Age, y | 32 (32.2 ± 9.5) | 33.5 (35.2 ± 8.6) | .25 |
Gender, F/M | 4/4 | 6/3 | .84 |
CD34+, 106/L | 1.0 (1.8 ± 1.2) | 2.0 (1.7 ± 0.9) | .90 |
WBC, 109/L | 6.61 (6.55 ± 1.72) | 4.47 (4.90 ± 2.07) | .05 |
Hemoglobin, g/L | 1.24 (1.32 ± 0.14) | 1.25 (1.32 ± 0.14) | .46 |
Platelet, 109/L | 256 (244 ± 32) | 265 (265 ± 96) | .28 |
ANC, 109/L | 4.20 (4.02 ± 1.65) | 1.93 (2.53 ± 1.49) | .04 |
Hematocrit, % | 38.2 (39.8 ± 4.5) | 37.7 (39.4 ± 4.1) | .42 |
Values are given as median (mean ± SD).
SCT indicates sickle cell trait; WBC, white blood cell; and ANC, absolute neutrophil count.